Cardiovascular Risks Associated With Contraceptive Use
Thomas Kimble, MD, reviews potential cardiovascular risks associated with some contraceptives.
EP: 1.Prevalence of Contraceptive Use in the US
EP: 2.Initiating Contraception Conversations With Patients
EP: 3.Communicating With Patients About Contraceptives
EP: 4.Role of Pharmacists and Other Healthcare Professionals in Contraceptive Counseling
EP: 5.Use of Hormonal Contraceptive Agents
EP: 6.Contraception for Patients With Higher BMI
EP: 7.Cardiovascular Risks Associated With Contraceptive Use
EP: 8.Overview of Approved Contraceptives: Drospirenone
EP: 9.Additional Methods of Contraception
EP: 10.Hormonal Patch and Vaginal Gel Contraceptives
EP: 11.Impact of Routes of Administration on Contraceptive Adherence
EP: 12.Benefits of Recently Approved Contraceptives
EP: 13.Educational Resources on Contraceptive Options
EP: 14.Unmet Needs in Contraception
Jenna Beckham, MD, MSPH, FACOG: We just talked more about the higher BMIs and sort of the efficacy and safety. What do you think about some of the studies that have shown a higher risk of some cardiovascular complications in combined hormonal contraceptive use with higher BMI patients?
Thomas Kimble, MD: There are a lot of studies, some from the United States and North America; some of them are from Europe. One thing I always consider when I'm looking at these studies is where was the clinical trial done because we're talking about 2 very different populations. In the United States you tend to have a higher BMI. In Europe you tend to have higher smoking and some other risk factors as well, so we must take those things into consideration. There was a study on a contraceptive product that a lot of us got concerned about using several years ago and when we looked further at the data, when you excluded women who had other risk factors there wasn't much of a risk in developing thromboembolic events. That's what the concern was so you really must look at some of these studies and use your judgement, look at where it was done, who was the population, did they control for other risk factors and just something to think about.
Jenna Beckham, MD, MSPH, FACOG: Right and as we've said earlier, just remembering that each patient is unique and individual and take all that data and help it inform your counseling and that decision but some of these things can help you with some guidance but not necessarily means it's not something that your patient can use especially in the absence of other risk factors. Certainly, if there are more risk factors to consider then that changes the equation.
Transcript edited for clarity
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Contemporary understanding of breast cancer risk with combined oral contraceptives
April 2nd 2024Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
Read More
